Visitor preview: 5 stories per page Create my free account
Events database

دواء الزهايمر الفموي الكوري K-يدخل منعطفاً حاسماً... نتائج الدراسة السريرية المرحلة الثالثة لـ AR1001 من شركة آري بايو محل انتظار

Advanced analysis (spheres, detailed sources, paid analyses)
Event date
exact date
Coverage
5 outlets · 5 articles
first · latest
Reporting countries
South Korea
Arabic, Spanish, Chinese
Countries concerned
South Korea
Health · intensity 0.0 · tone 0.00
In 5 seconds

Covered mainly by the Western sphere (100%); silent in Sino-Russian & BRICS, Arab-Muslim world, Global South.

Western 100%Sino-Russian & BRICS 0%Arab-Muslim world 0%Global South 0%

Global sphere reading. The left / centre / right reading is shown in the coverage analysis below.

In 30 seconds
  • Confirmed by 3 outlets in 1 countries.
  • Ignored by Sino-Russian & BRICS, Arab-Muslim world, Global South.
  • Propagation: first reported by arab.ajunews.com (South Korea), . No word-for-word republication detected.

Headline clash across the four spheres

Western
Sino-Russian & BRICS

No outlet in this sphere covers the event: blind spot.

Arab-Muslim world

No outlet in this sphere covers the event: blind spot.

Global South

No outlet in this sphere covers the event: blind spot.

Coverage analysis

Analyzing coverage…

Event sources

  1. دواء الزهايمر الفموي الكوري K-يدخل منعطفاً حاسماً... نتائج الدراسة السريرية المرحلة الثالثة لـ AR1001 من شركة آري بايو محل انتظار
    arab.ajunews.comKRSouth Korea → South KoreaArabic
  2. La aprobación del fármaco oral contra el Alzheimer de Corea del Sur: Ariabio centra la atención en los resultados del ensayo de fase 3 de 'AR1001'
    spain.ajunews.comKRSouth Korea → South KoreaSpanish
  3. Thuốc điều trị Alzheimer dạng uống của Hàn Quốc trước bước ngoặt thương mại hóa, giới đầu tư chờ kết quả thử nghiệm giai đoạn 3
    vietnam.kyungjeilbo.comKRSouth Korea → South KoreaChinese